TY - JOUR
T1 - Philadelphia chromosome-negative chronic myelogenous leukemia and chronic myelomonocytic leukemia
AU - Kantarjian, H. M.
AU - Kurzrock, R.
AU - Talpaz, M.
PY - 1990
Y1 - 1990
N2 - Philadelphia chromosome (Ph)-negative chronic myelogenous leukemia (CML) and chronic myelomonocytic leukemia (CMML) are heterogeneous disorders characterized by various degrees of proliferation, dysplasia, maturation arrest, and monocytosis. In this article, the clinical, laboratory, molecular and therapeutic aspects of the disease entities are reviewed.
AB - Philadelphia chromosome (Ph)-negative chronic myelogenous leukemia (CML) and chronic myelomonocytic leukemia (CMML) are heterogeneous disorders characterized by various degrees of proliferation, dysplasia, maturation arrest, and monocytosis. In this article, the clinical, laboratory, molecular and therapeutic aspects of the disease entities are reviewed.
UR - http://www.scopus.com/inward/record.url?scp=0025253450&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025253450&partnerID=8YFLogxK
U2 - 10.1016/s0889-8588(18)30494-5
DO - 10.1016/s0889-8588(18)30494-5
M3 - Review article
C2 - 2182598
AN - SCOPUS:0025253450
SN - 0889-8588
VL - 4
SP - 389-404+vi
JO - Hematology/Oncology Clinics of North America
JF - Hematology/Oncology Clinics of North America
IS - 2
ER -